HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Maria Alejandra Mogollon, Speaker at Weight Management Conferences
America Association of Clinical Endocrinologist, United States

Abstract:

We are excited to present a groundbreaking session at the World Obesity Conference 2024, led by a distinguished expert in the field. This presentation will provide an in-depth exploration of clinically meaningful weight loss thresholds and innovative approaches to managing obesity complications. Attendees will gain valuable insights into the application of Anti-Obesity Medications (AOMs), the impact of combination therapies including SGLT-2 and GLP-1 inhibitors, and the latest advancements in obesity treatment strategies.

Audience take away notes:

  • Clarifying AOMs: Address common misconceptions surrounding anti-obesity medications and their clinical applications.
  • Understanding Obesity: Recognize obesity as a chronic, progressive disease that necessitates early and aggressive intervention.
  • Pharmacotherapy Insights: Delve into the latest evidence on AOMs, including their indications, contraindications, and optimal use.
  • Evidence-Based Practices: Implement cutting-edge recommendations for effective obesity treatment based on the latest research.

Biography:

Dr. Maria A. Mogollon graduated from medical school in Venezuela in 1996 and completed her specialization in Internal Medicine in 2002. With over 20 years of experience in diabetes and obesity in her country. She currently practices as an APRN specializing in Diabetes and Obesity in the USA. In addition to her clinical role, Dr. Mogollon serves as a Clinical Faculty member at Miami Regional University and faculty member and collaborator with the American Association of Clinical Endocrinologists (AACE).

Watsapp